Overview

Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)

Status:
Completed
Trial end date:
2008-03-12
Target enrollment:
Participant gender:
Summary
To evaluate the effect of treatment with sitagliptin compared to placebo in elderly patients with type 2 diabetes mellitus who have poor glycemic control with diet and exercise.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Sitagliptin Phosphate